DK0983273T3 - Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler - Google Patents

Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler

Info

Publication number
DK0983273T3
DK0983273T3 DK98921294T DK98921294T DK0983273T3 DK 0983273 T3 DK0983273 T3 DK 0983273T3 DK 98921294 T DK98921294 T DK 98921294T DK 98921294 T DK98921294 T DK 98921294T DK 0983273 T3 DK0983273 T3 DK 0983273T3
Authority
DK
Denmark
Prior art keywords
ethylene glycol
glycol esters
photoactive agents
monohydrobenzoporphyrin
derivatives
Prior art date
Application number
DK98921294T
Other languages
Danish (da)
English (en)
Inventor
Ethan Sternberg
Anna M Richter
David W C Hunt
Jain Ashok
David Dolphin
Julia G Levy
Ashok Jain
Elizabeth M Waterfield
Original Assignee
Univ British Columbia
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia, Quadra Logic Tech Inc filed Critical Univ British Columbia
Application granted granted Critical
Publication of DK0983273T3 publication Critical patent/DK0983273T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK98921294T 1997-05-07 1998-05-06 Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler DK0983273T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85249497A 1997-05-07 1997-05-07
PCT/CA1998/000468 WO1998050387A1 (en) 1997-05-07 1998-05-06 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents

Publications (1)

Publication Number Publication Date
DK0983273T3 true DK0983273T3 (da) 2002-04-22

Family

ID=25313492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98921294T DK0983273T3 (da) 1997-05-07 1998-05-06 Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler

Country Status (21)

Country Link
US (2) US5929105A (cs)
EP (2) EP1177795B1 (cs)
JP (1) JP3378889B2 (cs)
KR (1) KR100397131B1 (cs)
CN (1) CN1113882C (cs)
AR (1) AR012673A1 (cs)
AT (1) ATE211473T1 (cs)
AU (1) AU741070B2 (cs)
CA (1) CA2284879C (cs)
CZ (1) CZ294715B6 (cs)
DE (1) DE69803376T2 (cs)
DK (1) DK0983273T3 (cs)
ES (2) ES2171022T3 (cs)
HK (1) HK1042439B (cs)
HU (1) HU221754B1 (cs)
IL (1) IL132066A (cs)
NO (1) NO314264B1 (cs)
NZ (1) NZ338031A (cs)
PL (1) PL202341B1 (cs)
PT (1) PT983273E (cs)
WO (1) WO1998050387A1 (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756396B1 (en) * 1997-05-07 2004-06-29 Qlt Inc. Ethylene glycol esters as photoactive agents
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6331235B1 (en) * 1998-12-11 2001-12-18 The University Of British Columbia Chiral separation of benzoporphyrin derivative mono-and di-acids by laser-induced fluorescence capillary electrophoresis
US6344050B1 (en) 1998-12-21 2002-02-05 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
US6454789B1 (en) 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
CA2356532A1 (en) * 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
AU2789900A (en) * 1999-02-26 2000-09-21 Qlt Phototherapeutics, Inc. Photodynamic therapy in combination with apoptosis inducing factors
GB9905911D0 (en) * 1999-03-15 1999-05-05 Photocure As Method
US6609014B1 (en) 1999-04-14 2003-08-19 Qlt Inc. Use of PDT to inhibit intimal hyperplasia
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US7122568B1 (en) 1999-11-17 2006-10-17 Qlt, Inc. Use of low-dose PDT to inhibit restenosis
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
WO2001051087A2 (en) * 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
WO2001085213A2 (en) 2000-05-08 2001-11-15 The University Of British Columbia Supports for photosensitizer formulations
US6693093B2 (en) 2000-05-08 2004-02-17 The University Of British Columbia (Ubc) Drug delivery systems for photodynamic therapy
ES2445579T3 (es) * 2000-11-29 2014-03-04 Pci Biotech As Internalización fotoquímica para el suministro de moléculas mediado por virus en el citosol
CZ301427B6 (cs) * 2000-11-29 2010-02-24 Pci Biotech As Zpusob zavedení molekuly do cytosolu bunky
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
JP2004532251A (ja) * 2001-05-31 2004-10-21 ミラヴァント ファーマシューティカルズ インコーポレイテッド 光線力学療法で使用のメタロテトラピロール系光増感剤
ATE419010T1 (de) * 2001-08-22 2009-01-15 Univ Montana State Porphyrine mit verbesserten multi-photonen- absorptionsquerschnitten für die photodynamische therapie
ATE390121T1 (de) * 2001-11-02 2008-04-15 Univ Alberta Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator
NZ533037A (en) * 2001-11-09 2006-06-30 Quadra Logic Tech Inc Photodynamic therapy for the treatment of hair loss
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
CA2437638A1 (en) * 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) * 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
US20120034155A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
RU2561729C2 (ru) 2009-07-08 2015-09-10 Дермира (Канада), Инк. Аналоги tofa, применимые при лечении дерматологических расстройств или состояний
HUE034119T2 (en) 2010-02-04 2018-01-29 Morphotek Inc Chlorotoxin polypeptides and conjugates and uses thereof
AU2012205410A1 (en) 2011-01-13 2013-08-01 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
WO2013003507A1 (en) 2011-06-27 2013-01-03 Morphotek, Inc. Multifunctional agents
AU2012328679C1 (en) 2011-10-25 2018-10-25 Memorial Sloan-Kettering Cancer Center Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer
AU2013290140A1 (en) 2012-07-11 2015-01-29 Dermira, Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
AU2013334102B2 (en) 2012-10-26 2018-08-16 Memorial Sloan-Kettering Cancer Center Modulators of resistant androgen receptor
AU2014370182B2 (en) 2013-12-23 2021-07-15 Memorial Sloan-Kettering Cancer Center Methods and compositions for treating cancer using peptide nucleic acid-based agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US4883790A (en) 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
CA2056431A1 (en) * 1989-06-07 1990-12-08 David Dolphin Photosensitizing diels-alder porphyrin derivatives
US5498710A (en) * 1994-04-22 1996-03-12 Health Research, Inc. Alkyl ether analogues of benzoporphyrin derivatives
CN1120166C (zh) * 1997-05-07 2003-09-03 不列颠哥伦比亚省大学 新一类的苯并卟啉光活性化合物

Also Published As

Publication number Publication date
EP0983273B8 (en) 2002-10-09
HK1042439B (en) 2014-02-28
CZ392399A3 (cs) 2000-02-16
EP1177795B1 (en) 2013-09-11
JP3378889B2 (ja) 2003-02-17
NO314264B1 (no) 2003-02-24
PL202341B1 (pl) 2009-06-30
HU221754B1 (hu) 2002-12-28
ES2171022T3 (es) 2002-08-16
CZ294715B6 (cs) 2005-02-16
DE69803376D1 (de) 2002-02-28
CN1113882C (zh) 2003-07-09
AU741070B2 (en) 2001-11-22
CA2284879C (en) 2005-10-25
IL132066A0 (en) 2001-03-19
WO1998050387A1 (en) 1998-11-12
CN1254339A (zh) 2000-05-24
ES2437790T3 (es) 2014-01-14
KR20010012331A (ko) 2001-02-15
CA2284879A1 (en) 1998-11-12
AU7420798A (en) 1998-11-27
US6153639A (en) 2000-11-28
HUP0003604A2 (hu) 2001-02-28
PL336790A1 (en) 2000-07-17
AR012673A1 (es) 2000-11-08
DE69803376T2 (de) 2002-08-14
IL132066A (en) 2008-06-05
NO995436L (no) 2000-01-04
NZ338031A (en) 2001-04-27
EP1177795A3 (en) 2002-05-29
US5929105A (en) 1999-07-27
ATE211473T1 (de) 2002-01-15
JP2001507369A (ja) 2001-06-05
EP0983273B1 (en) 2002-01-02
EP1177795A2 (en) 2002-02-06
KR100397131B1 (ko) 2003-09-13
PT983273E (pt) 2002-06-28
NO995436D0 (no) 1999-11-05
HUP0003604A3 (en) 2002-04-29
EP0983273A1 (en) 2000-03-08

Similar Documents

Publication Publication Date Title
DK0983273T3 (da) Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler
NO20014412L (no) Forbindelser nyttige som anti-inflammatoriske midler
NO20002173D0 (no) Pleuromutilin-derivater som antimikrobielle midler
NO20013559L (no) Aromatiske heterocykliske forbindelser som anti- inflammatoriske midler
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
NO992725L (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
NO971137L (no) Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser
FI951001A0 (fi) Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina
ATE365276T1 (de) Mehrachsige turbine
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO990435D0 (no) Fremstilling av estere som overflateaktive midler
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
NO972887D0 (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
NO20020457D0 (no) Benzenaminderivater som antikoagulanter
DK1075471T3 (da) Idolylderivater som serotonerge midler
NO20001200D0 (no) Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase
NO20002321D0 (no) Bifenylderivater som farmasøytiske midler
NO972905D0 (no) Tienoksasinon-derivater anvendelige som antivirusmidler
FI980557A0 (fi) Foerfarande vid kalandrering av pappersbana och kalander som tillaempar foerfarandet
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
NO20021249D0 (no) Tienoisoksazolfenoksyusubstituerte etyl- og propylderivater som D4antagonister
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
DK0980383T3 (da) Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener